How should we plan our launch sequencing across European countries, considering timelines for approval, pricing, and access?
How should we plan our launch sequencing across European countries, considering timelines for approval, pricing, and access?
What's Inside the Q&A:
Strategic Launch Sequencing
– How to prioritize European markets for maximum early revenue and avoid costly timing mistakes.
Germany First Wave Strategy
– Why Germany’s unique reimbursement system makes it the optimal starting point for most launches.
Reference Pricing Navigation
– Critical timing decisions that prevent low-price markets from undermining your premium pricing strategy.
Early Access Program Leverage
– Parallel pathways to reach patients and generate revenue while formal pricing negotiations continue.
